Ilka B. Schiffer

725 total citations
13 papers, 512 citations indexed

About

Ilka B. Schiffer is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Ilka B. Schiffer has authored 13 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Ilka B. Schiffer's work include HER2/EGFR in Cancer Research (5 papers), Cell Adhesion Molecules Research (3 papers) and Ultrasound and Hyperthermia Applications (3 papers). Ilka B. Schiffer is often cited by papers focused on HER2/EGFR in Cancer Research (5 papers), Cell Adhesion Molecules Research (3 papers) and Ultrasound and Hyperthermia Applications (3 papers). Ilka B. Schiffer collaborates with scholars based in Germany, Tunisia and Netherlands. Ilka B. Schiffer's co-authors include Jan G. Hengstler, M Schmidt, Matthias Hermes, Franz Oesch, Susanne Gebhard, Berno Tanner, Eric Steiner, Marc Brulport, Wiebke Schormann and Dirk Hasenclever and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Ilka B. Schiffer

13 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ilka B. Schiffer Germany	11	243	233	112	97	59	13	512
Jeannie E. Maglione United States	9	280 1.2×	306 1.3×	62 0.6×	168 1.7×	24 0.4×	9	621
Arnaud Blomme Belgium	14	402 1.7×	188 0.8×	37 0.3×	174 1.8×	83 1.4×	21	736
Rong-Hua Tao United States	12	430 1.8×	152 0.7×	117 1.0×	47 0.5×	34 0.6×	17	648
Hong‐Jun Liao United States	8	308 1.3×	162 0.7×	87 0.8×	38 0.4×	69 1.2×	11	485
Lisa Ley United States	14	273 1.1×	326 1.4×	64 0.6×	108 1.1×	89 1.5×	30	655
Verónica Calvo United States	9	265 1.1×	218 0.9×	23 0.2×	167 1.7×	51 0.9×	13	513
Kathryn M. Kinross Australia	9	409 1.7×	158 0.7×	54 0.5×	88 0.9×	77 1.3×	16	632
Soumya Ullas United States	8	398 1.6×	139 0.6×	27 0.2×	138 1.4×	56 0.9×	11	649
Fabiana Lüönd Switzerland	7	380 1.6×	330 1.4×	47 0.4×	237 2.4×	95 1.6×	9	683
Thai H. Tran United States	18	494 2.0×	426 1.8×	18 0.2×	155 1.6×	83 1.4×	31	853

Countries citing papers authored by Ilka B. Schiffer

Since Specialization

Citations

This map shows the geographic impact of Ilka B. Schiffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilka B. Schiffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilka B. Schiffer more than expected).

Fields of papers citing papers by Ilka B. Schiffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilka B. Schiffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilka B. Schiffer. The network helps show where Ilka B. Schiffer may publish in the future.

Co-authorship network of co-authors of Ilka B. Schiffer

This figure shows the co-authorship network connecting the top 25 collaborators of Ilka B. Schiffer. A scholar is included among the top collaborators of Ilka B. Schiffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilka B. Schiffer. Ilka B. Schiffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hermes, Matthias, Wiebke Schormann, Marc Brulport, et al.. (2008). Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model. British Journal of Cancer. 98(9). 1525–1532. 10 indexed citations

Schmidt, Marcus, E. Bremer, Dirk Hasenclever, et al.. (2007). Role of the progesterone receptor for paclitaxel resistance in primary breast cancer. British Journal of Cancer. 96(2). 241–247. 21 indexed citations

Schiffer, Ilka B., Susanne Gebhard, Berno Tanner, et al.. (2006). Dephosphorylation of p‐ERK1/2 in relation to tumor remission after HER‐2 and Raf1 blocking therapy in a conditional mouse tumor model. Molecular Carcinogenesis. 45(5). 302–308. 11 indexed citations

Hengstler, Jan G., Ernesto Bockamp, Matthias Hermes, et al.. (2006). Oncogene-Blocking Therapies: New Insights from Conditional Mouse Tumor Models. Current Cancer Drug Targets. 6(7). 603–612. 17 indexed citations

Tanner, Berno, Dirk Hasenclever, Wiebke Schormann, et al.. (2006). ErbB-3 Predicts Survival in Ovarian Cancer. Journal of Clinical Oncology. 24(26). 4317–4323. 171 indexed citations

Spangenberg, Christian, Ekkehart Lausch, Dirk Prawitt, et al.. (2006). ERBB2-Mediated Transcriptional Up-regulation of the α5β1 Integrin Fibronectin Receptor Promotes Tumor Cell Survival Under Adverse Conditions. Cancer Research. 66(7). 3715–3725. 57 indexed citations

Lausch, Ekkehart, Steffen Schmitt, Thorsten Enklaar, et al.. (2005). Premature Senescence Is a Primary Fail-safe Mechanism of ERBB2-Driven Tumorigenesis in Breast Carcinoma Cells. Cancer Research. 65(3). 840–849. 70 indexed citations

Tanner, Berno, Ilka B. Schiffer, M Schmidt, et al.. (2003). Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas. Gynecologic Oncology. 92(2). 568–577. 32 indexed citations

Schiffer, Ilka B., Wolfgang Schreiber, Robert Graf, et al.. (2003). No influence of magnetic fields on cell cycle progression using conditions relevant for patients during MRI. Bioelectromagnetics. 24(4). 241–250. 40 indexed citations

10.

Hengstler, Jan G., Henryk Pilch, M Schmidt, et al.. (2001). Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis. International Journal of Cancer. 95(2). 121–127. 50 indexed citations

11.

Hengstler, Jan G., et al.. (2001). Kryotherapie maligner Tumoren: Untersuchungen mittels MRT im Tierexperiment und Vergleich mit morphologischen Veränderungen*. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 173(7). 632–638. 4 indexed citations

12.

Schreiber, Wolfgang, Ilka B. Schiffer, J. Hast, et al.. (2001). Lack of mutagenic and co‐mutagenic effects of magnetic fields during magnetic resonance imaging. Journal of Magnetic Resonance Imaging. 14(6). 779–788. 25 indexed citations

13.

Hengstler, Jan G., Wolfgang Schreiber, Howard Georgi, et al.. (2000). Untersuchung eines möglichen mutagenen Potenzials von Magnetfeldern1. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 172(11). 934–939. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact